SEC Form 4 · accession 0001103780-15-000058

Lexaria Bioscience Corp. · LXRP

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — CEO · Director · 10% Owner

Period of report

Jan 20, 2010

Accepted (ET)

Nov 2, 2015 · 7:27 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001348362

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Shares	Oct 30, 2015	P	7,000	$0.1839	A	5,987,206	D
Common Shares	Oct 30, 2015	P	1,500	$0.179	A	5,988,706	D
Common Shares	Nov 2, 2015	P	5,000	$0.184	A	5,993,706	D
Common Shares^F1	Nov 2, 2015	P	1,500	$0.24	A	5,995,206	D
Common Shares^F2	Nov 2, 2015	P	10,000	$0.25	A	6,005,206	D
Common Shares	holding	—	—		—	4,488,958	I	Private Holding Company
Common Shares	holding	—	—		—	5,980,206	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Options	$0.11	holding	—	—	—	Dec 23, 2014	Dec 23, 2019	Common Shares	500,000	500,000	D
Stock Options	$0.35	holding	—	—	—	Jul 11, 2011	Jul 11, 2016	Common Shares	200,000	700,000	D
Stock Options	$0.10	holding	—	—	—	Jun 18, 2013	Jun 18, 2018	Common Shares	225,000	925,000	D
Warrants	$0.25	holding	—	—	—	May 15, 2015	May 15, 2017	Common Shares	170,000	170,000	I